AI Approach to Post-surgery Care for Crohn's Disease
AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease
Recruiting
Observational Study
Crohn Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 225 (estimated)
- Sponsor
- University College Cork · Other
Who this trial is looking for
This trial is looking for adults aged 18 to 75 who have Crohn's disease and have had recent intestinal surgery or plan to have surgery soon. If you join, you will help researchers develop a new way to predict how well you'll do after surgery.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 18 and 75 years old.
- I have been diagnosed with Crohn's disease for at least 6 months.
- I have had intestinal surgery within the last 3 months or have surgery planned.
You may not be able to join if
- I cannot provide consent.
- I have serious health issues that would make this unsafe.
- I have an ostomy.
- I am pregnant or breastfeeding.
- I cannot have a colonoscopy or biopsies.
- I have a rectum score of less than 2 plus issues in the left colon.
- I am allergic to nuts or shellfish.
- I have severe or uncontrolled asthma.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicentre prospective international observational study. This study aims to introduce a novel multidimensional approach to precision imaging, enabling the identification and stratification of high-risk patients who can potentially benefit from early treatments to halt the progression of Crohn's disease (CD). The investigators will develop a novel endoscopic assessment system using endo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged between 18 years and 75 years.
* Established diagnosis of CD at least six months prior to study.
* Patients who have undergone intestinal resection within 3 months before study entry or have surgery planned.
Exclusion Criteria:
* Inability to provide consent.
*…
Contacts